Exosome CDMO, GMP Manufacturing, Reagents & Services

Echo Biotech provides exosome CDMO and GMP manufacturing capabilities, GMP exosome materials, exosome reagents, omics services, and advanced exosome services for research and industrial translation.

Quick Facts

  • Exoomics® exosome multi-omics analysis platform
  • Echosome® engineered exosome platform
  • EchoPharm® scalable manufacturing platform
  • GoldenExo® exosome material series
  • Exosome reagents, quality analytics, multi-omics research, and CRO/CDMO services
  • 3000+ m² GMP labs, 2000+ key partners, 300+ publications, and 50+ intellectual property assets
  • Founded in 2017
  • Location: Beijing, China
  • Core platforms: Exoomics, Echosome and EchoPharm

Core Technology Platforms

Exoomics® supports exosome multi-omics profiling for disease research, companion diagnostics, therapy monitoring, and drug screening scenarios.

Echosome® supports engineered exosome delivery development for nucleic acid and protein payload directions.

EchoPharm® provides scalable exosome manufacturing, CMC scale-up, and production-related support for industrial translation.

Products and Services

The homepage links to GMP exosome materials, exosome reagents and research tools, quality analytics, multi-omics research, and advanced technical services.

GoldenExo® materials, exosome culture/purification/tracing/engineering reagents, and CRO/CDMO collaboration entry points form the main homepage content.

Company Capabilities

The homepage presents laboratory, GMP capability, campus, company video, collaboration metrics, publications, intellectual property, and news modules from the real website.

FAQ

Which Echo Biotech offering is the right starting point for a project?
Choose GMP exosome materials for raw-material needs, research reagents for in-house exosome workflows, and analytical or multi-omics services for sample testing and data generation. Projects that require cargo design, engineered exosome development, process scale-up, or GMP manufacturing should begin with a technical consultation.
When should a project consider custom engineered exosome or CDMO support?
Custom support is appropriate when an off-the-shelf product does not meet the required exosome source, payload, surface modification, process, scale, quality, or manufacturing objective. The final scope is confirmed through a project-specific technical assessment.
What information should be prepared before contacting Echo Biotech?
Helpful starting information includes the intended application, development stage, preferred EV source, payload or engineering goal, sample type and quantity, required deliverables, target scale, quality expectations, and desired timeline.